Skip to content
Back to PRVA

Privia Health Group, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
40
Purchases
0
Sales
40
Purchase value
$0.00
Sale value
$22.24M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 13, 2026Period of report Jul 9, 20260001759655-26-000057
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 9, 2026
Common Stock, par value $0.01 per shareF1F221,275$27.67$588.68K164,853Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 9, 2026Period of report Jul 7, 20260001858396-26-000016
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 7, 2026
Common Stock, par value $0.01 per shareF1F2600$27.57$16.54K186,128Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.55 to $27.58 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 2, 20260001401958-26-000010
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 6, 2026
Common Stock, par value $0.01 per shareF1F3F453,722$27.24$1.46M68,188Direct
SaleJul 2, 2026
Common Stock, par value $0.01 per shareF1F259,037$27.33$1.61M76,651Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.90 to $27.53 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.09 to $27.39 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4Reflects the forfeiture of 8,463 unvested restricted stock units granted on May 20, 2026 under the Issuer's 2021 Omnibus Incentive Plan.
  5. F5All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jul 7, 2026Period of report Jul 2, 20260001858396-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 2, 2026
Common Stock, par value $0.01 per shareF1F224,734$27.50$680.19K186,728Direct
Filing footnotes · 2
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.50 to $27.51 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed Jul 2, 2026Period of report Jun 30, 20260001759655-26-000053
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common Stock, par value $0.01 per shareF1F345,634$26.52$1.21M113,692Direct
SaleJul 1, 2026
Common Stock, par value $0.01 per shareF1F437,041$26.93$997.51K76,651Direct
SaleJun 30, 2026
Common Stock, par value $0.01 per shareF1F252,823$25.72$1.36M76,651Direct
Filing footnotes · 5
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.15 to $26.03 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $26.80 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.81 to $27.09 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. F5All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001759655-26-000048
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 29, 2026
Common Stock, par value $0.01 per shareF1F363,212$25.33$1.60M76,651Direct
SaleJun 26, 2026
Common Stock, par value $0.01 per shareF1F288,110$25.33$2.23M76,651Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.98 to $25.70 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.14 to $25.67 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Jun 30, 2026Period of report Jun 26, 20260001759655-26-000046
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 26, 2026
Common Stock, par value $0.01 per shareF1F217,196$25.18$433.00K211,462Direct
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.68 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
Parth MehrotraDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed May 13, 2026Period of report May 11, 20260001759655-26-000030
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 12, 2026
Common Stock, $0.01 par value per shareF315,647$22.64$354.25K434,357Direct
SaleMay 11, 2026
Common Stock, $0.01 par value per shareF1F2105,439$22.55$2.38M450,004Direct
Filing footnotes · 3
  1. F1Certain of the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and certain of the sales represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.28 to $23.10 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4
Filed May 13, 2026Period of report May 11, 20260001858396-26-000011
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Common Stock, par value $0.01 per shareF13,385$22.60$76.50K211,462Direct
Filing footnotes · 1
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed May 5, 2026Period of report May 1, 20260001858396-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 4, 2026
Common Stock, par value $0.01 per shareF11,206$25.00$30.15K214,847Direct
SaleMay 1, 2026
Common Stock, par value $0.01 per shareF1F27,179$25.03$179.69K214,847Direct
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.20 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed May 5, 2026Period of report May 1, 20260001759655-26-000020
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 4, 2026
Common Stock, par value $0.01 per shareF1F31,017$24.96$25.38K68,188Direct
SaleMay 1, 2026
Common Stock, par value $0.01 per shareF1F217,096$24.99$427.23K68,188Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $24.98 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4All stock options are fully vested and exercisable.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4
Filed Apr 6, 2026Period of report Apr 2, 20260001858396-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 2, 2026
Common Stock, par value $0.01 per shareF15,566$20.85$116.05K214,847Direct
Filing footnotes · 1
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Open on SEC EDGAR
Parth MehrotraDirector · Chief Executive Officer
4
Filed Mar 18, 2026Period of report Mar 16, 20260001858398-26-000006
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common Stock, $0.01 par value per shareF126,509$22.11$586.11K555,443Direct
Filing footnotes · 1
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4
Filed Mar 18, 2026Period of report Mar 16, 20260001759655-26-000019
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 16, 2026
Common Stock, par value $0.01 per shareF16,391$22.11$141.31K220,413Direct
Filing footnotes · 1
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Open on SEC EDGAR
Parth MehrotraDirector · Chief Executive Officer
4
Filed Mar 16, 2026Period of report Mar 12, 20260001858398-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common Stock, $0.01 par value per shareF127,229$21.52$585.97K581,952Direct
SaleMar 12, 2026
Common Stock, $0.01 par value per shareF126,763$21.90$586.11K609,181Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4
Filed Mar 16, 2026Period of report Mar 12, 20260001858396-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 13, 2026
Common Stock, par value $0.01 per shareF16,565$21.52$141.28K226,804Direct
SaleMar 12, 2026
Common Stock, par value $0.01 per shareF16,453$21.90$141.32K233,369Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of performance stock units.
Open on SEC EDGAR
Parth MehrotraDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Mar 12, 2026Period of report Mar 10, 20260001858398-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 10, 2026
Common Stock, $0.01 par value per shareF1F221,097$22.71$479.11K322,698Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person .
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.27 to $23.23 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
  4. F4Vesting and distribution to reporting person of 141,948 shares underlying performance stock units that were granted on May 9, 2023, and 29,956 shares underlying performance stock units that were granted on July 1, 2023, in both cases for the performance period 2023-2025.
Open on SEC EDGAR
Parth MehrotraDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000018
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF2F321,915$22.84$500.54K363,879Direct
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF2F41,219$23.37$28.49K362,660Direct
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF118,865$22.84$430.88K343,795Direct
SaleMar 6, 2026
Common Stock, $0.01 par value per shareF121,440$23.15$496.34K385,794Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
  2. F2The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.35 to $23.34 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.35 to $23.41 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Open on SEC EDGAR
Edward C FargisEVP & General Counsel
4
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000016
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 9, 2026
Common Stock, $0.01 par value per shareF14,949$22.84$113.04K83,711Direct
SaleMar 6, 2026
Common Stock, $0.01 par value per shareF14,394$23.15$101.72K88,660Direct
Filing footnotes · 1
  1. F1The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4
Filed Mar 10, 2026Period of report Mar 6, 20260001759655-26-000015
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMar 9, 2026
Common Stock, par value $0.01 per shareF15,829$22.84$133.13K161,903Direct
SaleMar 6, 2026
Common Stock, par value $0.01 per shareF15,177$23.15$119.85K167,732Direct
Filing footnotes · 1
  1. F1The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Mar 2, 2026Period of report Feb 26, 20260001759655-26-000013
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 27, 2026
Common Stock, par value $0.01 per shareF1F37,697$25.05$192.81K172,909Direct
SaleFeb 26, 2026
Common Stock, par value $0.01 per shareF1F25,361$25.00$134.03K172,909Direct
Filing footnotes · 4
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed Mar 2, 2026Period of report Feb 26, 20260001401958-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 27, 2026
Common Stock, par value $0.01 per shareF1F316,550$25.00$413.75K68,188Direct
SaleFeb 26, 2026
Common Stock, par value $0.01 per shareF1F27,788$24.99$194.62K68,188Direct
Filing footnotes · 4
  1. F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.13 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.15 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. F4All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
David MountcastleEVP & Chief Financial Officer
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 12, 20250001759655-25-000116
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 12, 2025
Common Stock, par value $0.01 per shareF1F223,887$25.03$597.89K172,909Direct
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.16 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3All of the stock options are fully vested and exercisable.
Open on SEC EDGAR
Matthew Shawn MorrisDirector
4Rule 10b5-1 plan disclosed
Filed Dec 16, 2025Period of report Dec 12, 20250001401958-25-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 12, 2025
Common Stock, par value $0.01 per shareF1F213,647$25.01$341.31K68,188Direct
Filing footnotes · 3
  1. F1This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.95 to $25.105 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. F3All of the stock options are fully vested and exercisable.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.